/PRNewswire/ --Neuralstem, Inc. (NYSE MKT: CUR) today reported that Eva Feldman, MD, PhD, principal investigator, will present updated Phase I data... ...
http://www.asianhhm.com/news/news_archives.asp?NewsID=44945/PRNewswire/ -- The College for Creative Studies (CCS) announced today that Ford Motor Company Fund will donate $1 million over five years,... ...
http://in.advfn.com/p.php?pid=nmona&article=57338807Neuralstem, Inc. has received approval from the US Food and Drug Administration (FDA) to commence a phase II trial using NSI-566 spinal... ...
http://www.pharmabiz.com/NewsDetails.aspx?aid=74888&sid=2/PRNewswire/ --Neuralstem, Inc. (NYSE MKT: CUR) today provided an update on its clinical trial programs and reported its 2012 financial results for... ...
http://www.asianhhm.com/news/news_archives.asp?NewsID=34461